Clinical Trial Update: Psilocybe Cubensis Mushrooms With or Without Fluoxetine for Refractory Depression [Phase 1, Phase 2]

View source ↗

Summary

An update on a Phase 1/2 clinical trial of psilocybin derived from Psilocybe cubensis mushrooms, with or without fluoxetine, for refractory depression, currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Fluoxetine (Fluoxetine)
• Psilocybin (psilocybin)

Snippet

Sponsor: Federal University of Latin American Integration | Conditions: Depressive Disorder | Phase 1, Phase 2 | Status: RECRUITING